Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445313 · ClinicalTrials.gov registry record
Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
A clinical trial, sponsored by Doheny Image Reading Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT02445313 is a clinical trial that has completed, run by Doheny Image Reading Center. The registered enrollment target is 100 participants.
The verdict
NCT02445313 has completed, sponsored by Doheny Image Reading Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.
Interventions
- DEVICE Nidek MP-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-02-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02445313
The ClinicalTrials.gov registry entry for NCT02445313 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Doheny Image Reading Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nidek MP-3 is the first listed.
NCT02445313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02445313 about?
NCT02445313 is a clinical study titled "Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device". The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participan...
What is the current status of trial NCT02445313?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-06. Estimated completion is 2019-02-12.
What interventions are being tested in trial NCT02445313?
The interventions under investigation include: Nidek MP-3 (DEVICE).
Who is sponsoring clinical trial NCT02445313?
This trial is sponsored by Doheny Image Reading Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.